Skip to main content
. 2018 Dec 5;36(3):453–459. doi: 10.1007/s10815-018-1380-5

Table 2.

Clinical outcomes of ERT cycles

Total (n = 302) Oral ERT (n = 156) Patch ERT (n = 146) p
Outcomes of fresh cycles Retrieved oocytes @ OPU (mean ± SD) 16.84 ± 9.17 17.58 ± 9.97 16.02 ± 8.15 a0.13
Metaphase II oocytes (mean ± SD) 14.25 ± 7.99 14.94 ± 8.52 13.49 ± 7.30 a0.14
ICSI-fertilized oocytes (mean ± SD) 11.83 ± 6.86 12.27 ± 7.25 11.33 ± 6.38 a0.25
Vitrified blastocyts (mean ± SD) 6.22 ± 4.17 6.25 ± 4.26 6.19 ± 4.08 a0.90
Embryo transfer day Day 5 (n, %) 290 (96.0) 151 (96.8) 139 (95.2) b0.480
Day 6 (n, %) 12 (4.0) 5 (3.2) 7 (4.8)
Blastocyst quality Poor quality blastocysts (n, %) 18 (6.0) 10 (6.4) 8 (5.5) b0.596
Good quality blastocysts (n, %) 85 (28.1) 40 (25.6) 45 (30.8)
Top quality blastocysts (n, %) 199 (65.9) 106 (67.9) 93 (63.7)
IVF outcomes Biochemical pregnancy (n, %) 216 (71.5) 118 (75.6) 98 (67.1) b0.101
Biochemical pregnancy loss (n, %) 18 (8.3) 9 (7.6) 9 (9.2) b0.680
Viable clinical pregnancy (n, %) 198 (65.6) 109 (69.9) 89 (61.0) b0.103
Clinical miscarriage (n, %) 34 (17.2) 21 (19.3) 13 (14.6) b0.387
Viable ongoing pregnancy (n, %) 164 (54.3) 88 (56.4) 76 (52.1) b0.448

aStudent’s t test, bPearson chi-square test